)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
Precipio (PRPO) investor relations material
Precipio Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary14 Aug, 2025
Executive summary
Q2 2025 delivered strong revenue growth in both pathology services and products divisions, with net sales rising 27% year-over-year to $5.7 million and gross margin improving from 39% to 43% due to higher case volume and operational efficiencies.
Net income turned positive at $0.07–$0.1 million, compared to a net loss of $1.2 million in Q2 2024, aided by non-recurring credits and improved cash performance.
Adjusted EBITDA improved by 87% year-over-year, and operating loss narrowed significantly.
Strategic investments in lab and facility expansion, as well as equipment purchases, modestly impacted near-term cash flow but support long-term growth.
Management expects to end 2025 cash flow positive and debt-free, with confidence in reaching breakeven without additional capital.
Financial highlights
Q2 2025 net sales reached $5.7 million, up 27% year-over-year and 15% sequentially; gross profit was $2.4 million (43% margin).
Net income for Q2 2025 was $0.07–$0.1 million; six-month net loss improved to $0.8 million from $3.3 million in the prior year.
Cash at June 30, 2025, was $1.1 million, with $0.3 million net cash provided by operating activities for the first half.
Cash used by operations decreased 71% year-over-year to $148K in Q2-2025.
Operating expenses for Q2 2025 were $3.3 million, mainly due to higher stock-based compensation and personnel costs.
Outlook and guidance
Management anticipates ending 2025 cash flow positive and debt-free, with no substantial capital expenditures or significant staff additions planned.
Substantial doubt remains about the ability to continue as a going concern without additional revenue growth or financing.
The company is evaluating the impact of the OBBBA on its tax position and financial outlook.
Approximately $3.7 million remains available for future equity sales under the 2023 Registration Statement.
Gross margins in pathology services are projected to level off at around 50% by 2026.
Elaborate on the send-out continuity program.
When will Pathology Services reach 50% margin?
Explain the distributor success story strategy.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Precipio earnings date
Q3 202517 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
)
Edge19 Sep 2025
American Express: An Empire of Plastic
How history, brand, and structure have steadily built American Express' moat, and why Warren Buffett still calls it a one-of-a-kind business.
Frequently asked questions
Precipio, Inc., a cancer diagnostics and reagent technology company, provides diagnostic products and services in the United States oncology market. The company delivers liquid biopsy products for the detection of genomic biomarkers, such as cell-free DNA (cfDNA) extracted from patient blood. Its integrated liquid biopsy platform combines proprietary CFDNA extraction and enrichment technology with third party sample preparation to enable the detection of tumor-specific cfDNA in multiple end-user clinical applications. The company is also involved in development of novel diagnostic products at its laboratories in Tempe and San Diego, California. Precipio, Inc. is based in San Diego, California.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage